TELMISARTAN FOR TREATING HYPERTENSION IN DOGS Russian patent published in 2024 - IPC A61K31/4184 A61K31/401 A61K45/06 A61P9/12 

FIELD: medicine; pharmaceutics.

SUBSTANCE: group of inventions refers to pharmaceutics, namely to the use of telmisartan for treating hypertension in a dog and a method of treating hypertension in a dog. Disclosed is the use of telmisartan or a pharmaceutically acceptable salt thereof in a therapeutically effective amount for the treatment of hypertension in a dog in need of such treatment, where a therapeutically effective amount of telmisartan is administered in a daily metered amount which varies during the treatment period, the daily metered amount of telmisartan for the first period of time during the treatment period is at least 1.0 mg/kg of body weight, and the daily metered amount of telmisartan is increased for a second period of time after the first period of time during the treatment period, where the daily metered amount of telmisartan is increased for the second period of time by an increase in range of 1.00 to 2.50 mg/kg of body weight. Method of treating hypertension in a dog in need of such treatment involves administering to the dog a therapeutically effective amount of telmisartan or a pharmaceutically acceptable salt thereof, wherein a therapeutically effective amount of telmisartan is administered in a daily metered amount which varies during the period of treatment, daily metered amount of telmisartan for the first period of time during the treatment period is at least 1.0 mg/kg of body weight, and the daily metered amount of telmisartan is increased for a second period of time after the first period of time during the treatment period, where the daily dosed amount of telmisartan is increased for the second period of time by an increase in range of 1.00 to 2.50 mg/kg of body weight.

EFFECT: group of inventions described above enables to effectively treat systemic hypertension in dogs.

21 cl, 4 dwg, 3 tbl, 2 ex